Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Epigenomics|September 26, 2017
Epigenetics of cancer-associated muscle catabolismRyan M Carr, Elisa Enriquez-Hesles, Rachel Lo Olson, et al.
The Journal of Biological Chemistry|September 17, 2020
E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axisValentina Montagnani, Luisa Maresca, Alessandro Apollo, et al.
Plos One|February 19, 2026
Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancerKhalid Jazieh, Erin E Carlson, Zafar Siddiqui, et al.
Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.
Medical Oncology (Northwood, London, England)|May 5, 2024
Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathwaysRobert A Gatenby, Kimberly A Luddy, Jamie K Teer, et al.
Nature Communications|March 18, 2022
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemiaMoritz Binder, Ryan M Carr, Terra L Lasho, et al.
Nature Communications|November 18, 2020
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXLSilvia Pietrobono, Giulia Anichini, Cesare Sala, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Spatial Conformation of Pancreatic Cancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant TherapyLuis H Cisneros, Merih D Toruner, Zafar Siddiqui, et al.
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
Pageof 4